1. Market Research
  2. > Pathology Industry

Breast Cancer Industry, February 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Mammography, Molecular Diagnostic, Pharmaceutical, Radiological Equipment, Therapeutics, Biomarker, Biopsy Device, Healthcare, Cancer Diagnostic, Medical, Therapy, Antibody, Antigen, Biosimilar, Cancer Drug, Radiation Therapy, Biochip, Diagnostic, Diagnostic Test.


 
1-10 of about 100 reports for Breast Cancer

Purchase Reports From Reputable Market Research Publishers

Surgical Devices - Medical Devices Pipeline Assessment, 2015

Surgical Devices - Medical Devices Pipeline Assessment, 2015

  • $ 4 000
  • Industry report
  • January 2016
  • by Global Data

Surgical Devices - Medical Devices Pipeline Assessment, 2015 Summary GlobalData's Medical Devices sector report, “Surgical Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of ...

Global Breast Cancer Partnering 2010 to 2016

Global Breast Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • February 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

 Hormone Refractory Breast Cancer-Pipeline Insights, 2016

Hormone Refractory Breast Cancer-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Hormone Refractory Breast Cancer-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hormone Refractory ...

Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, ...

Metastatic Breast Cancer - Pipeline Review, H2 2015

Metastatic Breast Cancer - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Metastatic Breast Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H2 2015’, provides an overview of the Metastatic Breast Cancer’s ...

Breast Cancer - Pipeline Review, H2 2015

Breast Cancer - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Breast Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H2 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report ...

Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence

Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence

  • $ 4 995
  • Industry report
  • December 2015
  • by GBI Research

Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence Summary Breast cancer, a malignant neoplasm, is the second ...

Breast Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

Breast Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

  • $ 4 795
  • Industry report
  • November 2015
  • by Transparency Market Research

This report on the breast cancer therapeutics market studies the current as well as future prospects of the market globally. The stakeholders of this report include pharmaceutical companies and intermediaries ...

About 6 700 reports for Breast Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • February 2013
    230 pages
  • Breast Cancer  

    Cancer  

    Public Health  

  • United States  

View report >

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.